Complications of retroperitoneal lymphadenectomy

Sago, Alvin L.; Ball, Thomas P.; Novicki, Donald E.

doi:10.1016/0090-4295(79)90410-2

Cited by 36 publications

(7 citation statements)

References 6 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Other authors reporting their experience with RPLND have encountered similar complications [8][9][10][11]. These reports usually combine patients undergoing surgery for lowand high-volume retroperitoneal disease, in smaller numbers and under different definitions.…”

Section: Other Complicationsmentioning

confidence: 99%

Complications of retroperitoneal lymph node dissection in testicular cancer: Primary and post-chemotherapy

Baniel

Sella

1999

Sem. Surg. Onc.

View full text Add to dashboard Cite

Retroperitoneal lymph node dissection (RPLND) is utilized in low‐stage testis cancer as a primary diagnostic and therapeutic procedure. In the post‐chemotherapy setting, it serves as an adjuvant procedure to resect residual tumor. Primary RPLND entails minimal resection of lymphatic tissue in the retroperitoneum; the complications are minor and insignificant. Wound infection is the main complication, affecting less than 5% of patients. Atelectasis and small bowel obstruction may occur in less than 2% of patients. In post‐chemotherapy RPLND, the template and the surgical challenge are much larger. Extensive tumor size, difficult location, adherence to major vessels, and vital structures, together with inferior pre‐operative status, are probably the main reasons for complications. The overall complication rate is 20% to 35% and mortality is 0.8% to 1%. Pulmonary insufficiency secondary to bleomycin‐induced interstitial fibrosis is the cause of the most severe side effects and mortality in these operations. Chylous ascites may occur, especially where resection of the inferior vena cava is necessary. Other complications occur to a lesser extent. A summary of all complications is presented and measures to avoid or manage them are depicted. Semin. Surg. Oncol. 17:263–267, 1999. © 1999 Wiley‐Liss, Inc.

show abstract

Section: Other Complicationsmentioning

confidence: 99%

Complications of retroperitoneal lymph node dissection in testicular cancer: Primary and post-chemotherapy

Baniel

Sella

1999

Sem. Surg. Onc.

View full text Add to dashboard Cite

show abstract

“…In centers experienced in RPLND, the mortality related to surgery equals zero [35][36][37]. In general, the surgical morbidity rate of RPLND is 8% to 35%, and is associated with the extent of metastatic tumor in the retroperitoneum [15,35,[37][38][39][40][41]. Since retroperitoneal tumor load is usually absent or limited to patients with clinical Stage I disease, major complications in these patients following primary RPLND are rare.…”

Section: Morbidity Of Surgerymentioning

confidence: 99%

“…Major peri-operative complications include hemorrhage, renal vascular injuries, aortic wall damage, ureteral injuries, unplanned nephrectomy, bowel obstruction, wound dehiscence, chylous ascites, pancreatitis, and thromboembolic events. Minor complications include prolonged ileus, wound infection, lymphocele, atelectasis, and urinary tract infection [15,35,[37][38][39][40][41].…”

Section: Morbidity Of Surgerymentioning

confidence: 99%

Surgery versus surveillance in stage I non-seminoma testicular cancer

Sonneveld¹,

Koops²,

Sleijfer³

et al. 1999

Sem. Surg. Onc.

View full text Add to dashboard Cite

Today, the standard treatment for patients with clinical Stage I non‐seminomatous testicular germ cell tumors (NSTGCT) following orchidectomy is either primary retroperitoneal lymph node dissection (RPLND) or close surveillance with cisplatin‐based polychemotherapy in case of a relapse. Both treatment modalities provide excellent overall survival rates up to 100%. Consequently, selection of the most appropriate management option is not primarily guided by survival considerations. The choice between the available options, each having its merits and its drawbacks, should be made based on a number of factors including treatment‐related morbidity, views and expertise of the physician, patient preferences, the expected degree of patient compliance, and prognostic factor analysis. To date, the role of adjuvant chemotherapy as an alternative management option for patients with clinical Stage I NSTGCT at high risk of occult metastases is limited. This systemic treatment modality would be a realistic alternative if the reliability of prognostic factors to identify high‐risk Stage I patients could be improved. This review addresses relevant issues in the management of patients with clinical Stage I NSTGCT to provide information that will allow a rational selection of the most appropriate management option. Semin. Surg. Oncol. 17:230–239, 1999. © 1999 Wiley‐Liss, Inc.

show abstract

“…SAGO et coli. (10) and WATERS et coIl. (15) had no such complications in 47 and 33 patients, respectively, whereas 2 cases of Iymphocysts and one case of intraperitoneal chyle were reported by V AHLEN-SIECK et coli.…”

Section: Resultsmentioning

confidence: 95%

Alterations in the CT Image following Retroperitoneal Lymphadenectomy in Early Stage Non-Seminomatous Testicular Tumor

Krogh¹,

Lien²,

Ous³

et al. 1985

Acta Radiologica. Diagnosis

View full text Add to dashboard Cite

CT was performed before and after lymphadenectomy in 105 patients with early stage non-seminomatous testicular tumor. Retroperitoneal blurring and retracted bowel were the most common findings and might cause interpretation problems. A reference CT making future comparison possible should be routinely performed two months after the operation.Retroperitoneal lymphadenectomy is widely used for pathologic staging and treatment of non-seminomatous germ cell tumors ofthe testis 0, 3,4,6,8,9,

show abstract

Complications of retroperitoneal lymphadenectomy

Cited by 36 publications

References 6 publications

Complications of retroperitoneal lymph node dissection in testicular cancer: Primary and post-chemotherapy

Complications of retroperitoneal lymph node dissection in testicular cancer: Primary and post-chemotherapy

Surgery versus surveillance in stage I non-seminoma testicular cancer

Alterations in the CT Image following Retroperitoneal Lymphadenectomy in Early Stage Non-Seminomatous Testicular Tumor

Contact Info

Product

Resources

About